RxDoctor Payments Data

Prathana Patel, APRN

Family · Brentwood, TNNPI 1518610443

Payments from drug & device makers

$990in general payments, 2019–2025

Across 50 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$183
  • Pfizer$161
  • GSK$150
  • AbbVie$94
  • Boston Scientific$75
  • Exact Sciences$65
  • plus $261 from 10 others

What the payments were for

  • Food & beverage$990100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$990 in reported general payments places this provider in the 60th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$9,017
Medicare patients
59
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl11$15,480
JanuviaSitagliptin Phosphate18$15,281
Albuterol Sulfate HfaAlbuterol Sulfate37$1,050
Rosuvastatin Calcium48$779
Atorvastatin Calcium79$654
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$605
Ezetimibe18$586
Metformin Hcl63$470
Famotidine22$463
Levothyroxine Sodium51$445
Montelukast Sodium34$389
Pantoprazole Sodium31$354
Losartan Potassium29$345
Dicyclomine Hcl14$335
Gabapentin24$316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$94$15,48011 claims
MerckJanuvia$14$15,28118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,706 family providers in Tennessee.

Other family in Brentwood

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →